Muralidhar Bali

CIK 00017841383 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001784138

Recent Transactions

30 trades

Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-07-22+30,000→ 30,000 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2024-05-22+30,000→ 30,000 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2023-06-06+17,500→ 17,500 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2023-05-25+30,000→ 30,000 total
Award
EXICURE, INC.$XCUR
Employee Stock Option (right to buy)
2022-06-13+50,000→ 50,000 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2022-05-25+22,500→ 22,500 total
Purchase
EXICURE, INC.$XCUR
Common Stock
2022-05-19$0.19/sh+1,472,126→ 8,449,126 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-07-14$8.50/sh+111,736→ 2,073,957 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-23$9.28/sh+20,710→ 1,962,221 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-22$8.72/sh+14,615→ 1,941,511 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-21$9.03/sh+32,659→ 1,926,896 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-08$9.50/sh+16,605→ 1,894,237 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-04$9.42/sh+257→ 1,877,632 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-06-03$9.25/sh+12,100→ 1,877,375 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2021-06-02+50,000→ 50,000 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-05-28$9.50/sh+14→ 1,865,275 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-05-27$9.26/sh+1,120→ 1,865,261 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-05-26$9.38/sh+5,915→ 1,864,141 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2021-05-20+10,000→ 10,000 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-04-13$15.00/sh+200,000→ 1,858,226 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-04-13+1,658,226→ 1,658,226 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Series B Preferred Stock
2021-04-13−7,420,232→ 0 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2021-04-08+14,000→ 14,000 total
Conversion
SPRUCE BIOSCIENCES, INC.$SPRB
Series B Preferred Stock
2020-10-14−10,416,666→ 0 total
Purchase
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock
2020-10-14$15.00/sh+200,000→ 1,792,518 total
Conversion
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock
2020-10-14+1,592,518→ 1,592,518 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2020-06-04+21,693→ 21,693 total
Purchase
EXICURE, INC.$XCUR
Common Stock $0.0001 par value
2019-12-19$2.75/sh+727,000→ 6,977,000 total
Award
EXICURE, INC.$XCUR
Stock option (right to buy)
2019-08-02+43,386→ 43,386 total

Muralidhar Bali

Recent Transactions

Companies

Recent Filings

Address